000 01246 a2200301 4500
005 20250516072230.0
264 0 _c20120913
008 201209s 0 0 eng d
022 _a1549-781X
024 7 _a10.3109/10408363.2011.646942
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFaiz, Fathimath
245 0 0 _aMolecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins.
_h[electronic resource]
260 _bCritical reviews in clinical laboratory sciences
_c
300 _a1-17 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aDyslipidemias
_xdrug therapy
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aHyperlipoproteinemia Type II
_xdrug therapy
650 0 4 _aRNA Splice Sites
_xgenetics
650 0 4 _aReceptors, LDL
_xgenetics
700 1 _aHooper, Amanda J
700 1 _avan Bockxmeer, Frank M
773 0 _tCritical reviews in clinical laboratory sciences
_gvol. 49
_gno. 1
_gp. 1-17
856 4 0 _uhttps://doi.org/10.3109/10408363.2011.646942
_zAvailable from publisher's website
999 _c21432575
_d21432575